B6.Cg-Pdgfrbtm1.1Rheu/Kctt

Status

Available to order

EMMA IDEM:02257
International strain nameB6.Cg-Pdgfrbtm1.1Rheu/Kctt
Alternative namePdgfrb-D849N
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolPdgfrbtmRheu
Gene/Transgene symbolPdgfrb

Information from provider

ProviderRainer Heuchel
Provider affiliationLudwig Institute for Cancer Research
Genetic informationThe Pdgfrb D849N mutation is an activating mutation conferring low constitutive receptor activity/autophosphorylation. A similar, but stronger, mutation (D842V) has been found in the PDGFRA gene in gastrointestistinal stromal tumors (GISTs) in humans. The targeting vector consisted of a 1.7-kb EcoRV-SpeI genomic 5'-fragment, followed by a PGKneobpA expression cassette flanked by loxP sites, a 5-kb SpeI-XhoI genomic 3'-fragment containing the point mutated exon 18, and a herpes simplex virus thymidine kinase expression cassette in pBluescript SK(+).
Phenotypic informationNo overt phenotype.
Breeding historyBackcrossed to C57BL/6ChR (N9), then cross with cre recombinase deleter strain (N6 in C57BL/6) to remove neo−cassette, then one backcross to C57BL/6.
References
  • A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity.;Chiara Federica, Goumans Marie-José, Forsberg Henrik, Ahgrén Aive, Rasola Andrea, Aspenström Pontus, Wernstedt Christer, Hellberg Carina, Heldin Carl-Henrik, Heuchel Rainer, ;2004;The Journal of biological chemistry;279;42516-27; 15284236
  • Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation.;Rolny Charlotte, Nilsson Ingrid, Magnusson Peetra, Armulik Annika, Jakobsson Lars, Wentzel Parri, Lindblom Per, Norlin Jenny, Betsholtz Christer, Heuchel Rainer, Welsh Michael, Claesson-Welsh Lena, ;2006;Blood;108;1877-86; 16690964

Information from EMMA

Archiving centreKarolinska Institutet, Stockholm, Sweden
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • enlarged heart / IMPC
  • decreased circulating fructosamine level / IMPC
  • increased circulating triglyceride level / IMPC
  • abnormal seminal vesicle morphology / IMPC
  • preweaning lethality, complete penetrance / IMPC
MGI phenotypes (gene matching)
  • abnormal angiogenesis / MGI
  • abnormal heart morphology / MGI
  • overriding aortic valve / MGI
  • enlarged heart / MGI
  • double outlet right ventricle / MGI
  • schistocytosis / MGI
  • short snout / MGI
  • abnormal pulmonary artery morphology / MGI
  • abnormal kidney blood vessel morphology / MGI
  • kidney hemorrhage / MGI
  • decreased body size / MGI
  • anemia / MGI
  • abnormal blood vessel morphology / MGI
  • thymus hypoplasia / MGI
  • hemorrhage / MGI
  • intracranial hemorrhage / MGI
  • perinatal lethality / MGI
  • abnormal eye morphology / MGI
  • abnormal kidney physiology / MGI
  • no abnormal phenotype detected / MGI
  • disorganized myocardium / MGI
  • hydrops fetalis / MGI
  • abnormal erythrocyte morphology / MGI
  • micrognathia / MGI
  • anisocytosis / MGI
  • poikilocytosis / MGI
  • dilated heart right ventricle / MGI
  • abnormal retinal vasculature morphology / MGI
  • increased vascular permeability / MGI
  • retinal detachment / MGI
  • dilated heart atrium / MGI
  • cardiac fibrosis / MGI
  • thrombocytopenia / MGI
  • abnormal placenta vasculature / MGI
  • abnormal embryonic hematopoiesis / MGI
  • kidney cysts / MGI
  • pallor / MGI
  • abnormal pericyte morphology / MGI
  • abnormal retinal layer morphology / MGI
  • abnormal heart left ventricle morphology / MGI
  • abnormal venule morphology / MGI
  • right aortic arch / MGI
  • abnormal basement membrane morphology / MGI
  • abnormal trophoblast layer morphology / MGI
  • polychromatophilia / MGI
  • increased susceptibility to injury / MGI
  • glomerulosclerosis / MGI
  • abnormal renal glomerulus morphology / MGI
  • abnormal mesangial cell morphology / MGI
  • renal/urinary system phenotype / MGI
  • homeostasis/metabolism phenotype / MGI
  • cardiovascular system phenotype / MGI
  • vision/eye phenotype / MGI
  • decreased angiogenesis / MGI
  • abnormal vascular endothelial cell morphology / MGI
  • increased vascular endothelial cell number / MGI
  • retinal hemorrhage / MGI
  • eye hemorrhage / MGI
  • clinodactyly / MGI
  • decreased retinal ganglion cell number / MGI
  • retinal ganglion cell degeneration / MGI
  • absent podocytes / MGI
  • increased heart ventricle size / MGI
  • abnormal placental labyrinth vasculature morphology / MGI
  • petechiae / MGI
  • increased nucleated erythrocyte cell number / MGI
  • eye opacity / MGI
  • abnormal retinal blood vessel morphology / MGI
  • abnormal retinal blood vessel pattern / MGI
  • ventricular septal defect / MGI
  • atrioventricular septal defect / MGI
  • perimembraneous ventricular septal defect / MGI
  • muscular ventricular septal defect / MGI
  • kidney microaneurysm / MGI
  • vascular ring / MGI
  • abnormal left subclavian artery morphology / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • perinatal lethality, incomplete penetrance / MGI
  • lethality throughout fetal growth and development, incomplete penetrance / MGI
  • decreased glomerular capillary number / MGI
  • absent mesangial cell / MGI
  • glomerulus hemorrhage / MGI
  • decreased kidney cell proliferation / MGI
  • glomerular capillary thrombosis / MGI
  • skin hemorrhage / MGI
  • purpura / MGI
  • decreased fibroblast proliferation / MGI
  • abnormal fibroblast migration / MGI
  • decreased fibroblast apoptosis / MGI
  • abnormal blood-retinal barrier function / MGI
  • increased retinal apoptosis / MGI

Literature references

  • A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity.;Chiara Federica, Goumans Marie-José, Forsberg Henrik, Ahgrén Aive, Rasola Andrea, Aspenström Pontus, Wernstedt Christer, Hellberg Carina, Heldin Carl-Henrik, Heuchel Rainer, ;2004;The Journal of biological chemistry;279;42516-27; 15284236
  • Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation.;Rolny Charlotte, Nilsson Ingrid, Magnusson Peetra, Armulik Annika, Jakobsson Lars, Wentzel Parri, Lindblom Per, Norlin Jenny, Betsholtz Christer, Heuchel Rainer, Welsh Michael, Claesson-Welsh Lena, ;2006;Blood;108;1877-86; 16690964

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).